Acute kidney injury secondary to severe delayed haemolysis in intravenous artesunate use for severe malaria

被引：4

作者：

Leong, Kai Wen ^{[1
]}

Singh, Kasha P. ^{[2
,3
]}

Leder, Karin ^{[2
,4
]}

Tong, Steven Y. C. ^{[2
,3
]}

机构：

[1] Royal Melbourne Hosp, Victorian Infect Dis Serv, Melbourne, Vic, Australia

[2] Royal Melbourne Hosp, Victorian Infect Dis Serv, Peter Doherty Inst Infect & Immun, Melbourne, Vic, Australia

[3] Univ Melbourne, Peter Doherty Inst Infect & Immun, Dept Infect Dis, Melbourne, Vic, Australia

[4] Monash Univ, Sch Publ Hlth & Prevent Med, Melbourne, Vic, Australia

来源：

BMJ CASE REPORTS | 2021年 / 14卷 / 01期

关键词：

drugs: infectious diseases; tropical medicine (infectious disease); acute renal failure; haematology (incl blood transfusion);

D O I：

10.1136/bcr-2020-237501

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

The use of artemisinin derivatives has been recommended by the WHO guidelines in malaria treatment largely due to its rapid parasite clearance and safety profile. This case report details the development of delayed haemolysis and subsequent severe acute kidney injury (AKI) 13 days after commencing intravenous artesunate treatment for malaria in an Australian returned traveller. Delayed haemolysis may be an under-recognised complication following artesunate use and if severe, can be complicated by AKI. Therefore, close patient follow-up following treatment is required to ensure prompt recognition of this phenomenon.

引用

页数：3

共 13 条

[1] [Anonymous], 2019, MALARIA CTR DIS CONT
[2] da Silva GB, 2017, REV INST MED TROP SP, V59, DOI [10.1590/S1678-9946201759053, 10.1590/s1678-9946201759053]
[3] Postartesunate delayed hemolysis is a predictable event related to the lifesaving effect of artemisinins
Jaureguiberry, Stephane
Ndour, Papa A.
Roussel, Camille
Ader, Flavie
Safeukui, Innocent
Nguyen, Marie
Biligui, Sylvestre
Ciceron, Liliane
Mouri, Oussama
Kendjo, Eric
Bricaire, Francois
Vray, Muriel
Angoulvant, Adela
Mayaux, Julien
Haldar, Kasturi
Mazier, Dominique
Danis, Martin
Caumes, Eric
Thellier, Marc
Buffet, Pierre
[J]. BLOOD, 2014, 124 (02) : 167 - 175
[4] Perazella MA., 2019, PREVENTION TREATMENT
[5] Severe falciparum malaria treated with artesunate complicated by delayed onset haemolysis and acute kidney injury
Plewes, Katherine
Haider, Md Shafiul
Kingston, Hugh W. F.
Yeo, Tsin W.
Ghose, Aniruddha
Hossain, Md Amir
Dondorp, Arjen M.
Turner, Gareth D. H.
Anstey, Nicholas M.
[J]. MALARIA JOURNAL, 2015, 14
[6] Correlation of biomarkers for parasite burden and immune activation with acute kidney injury in severe falciparum malaria
Plewes, Katherine
Royakkers, Annick A.
Hanson, Josh
Hasan, Md Mahtab Uddin
Alam, Shamsul
Ghose, Aniruddha
Maude, Richard J.
Stassen, Pauline M.
Charunwatthana, Prakaykaew
Lee, Sue J.
Turner, Gareth D. H.
Dondorp, Arjen M.
Schultz, Marcus J.
[J]. MALARIA JOURNAL, 2014, 13
[7] Haemolysis associated with the treatment of malaria with artemisinin derivatives: a systematic review of current evidence
Rehman, Khalid
Loetsch, Felix
Kremsner, Peter G.
Ramharter, Michael
[J]. INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES, 2014, 29 : 268 - 273
[8] Cell-free hemoglobin limits nitric oxide bioavailability in sickle-cell disease
Reiter, CD
Wang, XD
Tanus-Santos, JE
Hogg, N
Cannon, RO
Schechter, AN
Gladwin, MT
[J]. NATURE MEDICINE, 2002, 8 (12) : 1383 - 1389
[9] Delayed haemolysis after artesunate treatment of severe malaria - Review of the literature and perspective
Rolling, Thierry
Agbenyega, Tsiri
Krishna, Sanjeev
Kremsner, Peter G.
Cramer, Jakob P.
[J]. TRAVEL MEDICINE AND INFECTIOUS DISEASE, 2015, 13 (02) : 143 - 149
[10] Artesunate to treat severe malaria in travellers: review of efficacy and safety and practical implications
Roussel, Camille
Caumes, Eric
Thellier, Marc
Ndour, Papa Alioune
Buffet, Pierre A.
Jaureguiberry, Stephane
[J]. JOURNAL OF TRAVEL MEDICINE, 2017, 24 (02) : 1 - 9

← 1 2 →